logo
  1. Home
  2. Stocks
  3. Alkem Laboratories

Alkem Laboratories Share Price

Mid Cap | Pharmaceuticals and health care | NSE: ALKEM | BSE: 539523

₹4,828.70 image-142.85 (-2.87 %)

Last Updated: 04 Apr 2025 03:55 PM

Technicalsimage BULLISHimage

Overview

Open (₹) 4,900.00

High (₹) 4,929.25

Low (₹) 4,738.55

Prev. Close (₹) 4,971.55

Volume 83,897

VWAP (₹) 4,625.15

ROCE (%) 19.49

Industry P/E 44.73

TTM P/E 26.81

P/B Ratio 5.39

Market Cap (₹) Cr.57,734.35

Dividend Yield (%)0.83

EPS (₹) 150.19

ROE16.76%

Sales Growth (%) 9.21

Profit Growth (%)79.92

Day Range

4,929.254,929.25

L
H

52 Week Range

4,409.906,440.00

L
H

Historical Returns

Returns (6M)

-21.62 %

Returns (1Y)

-1.71 %

Returns (3Y)

38.21 %

Returns (5Y)

107.77 %

Returns (6M)

-21.62 %

Returns (1Y)

-1.71 %

Returns (3Y)

38.21 %

Returns (5Y)

107.77 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (82.47%) TTM EPS Growth
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Company with 82.47% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BULLISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 25.77

MFI 37.31

ATR 165.29

Commodity Channel Index -62.40

ROC125 -22.55

ROC21 -8.00

Williams %R -74.39

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current4,790.354,934.505,083.854,641.004,496.854,347.504,203.35
Week Ago4,703.464,805.684,866.364,642.784,540.564,479.884,377.66
Month Ago4,964.195,012.325,059.794,916.724,868.594,821.124,772.99

EMA & SMA
info_icon

4828.70

Current Price

EMA & SMApin

Bullish Moving Averages

11

Bearish Moving Averages

9

5 Day 4604.78

9 Day 4693.16

10 Day 4663.56

12 Day 4680.32

14 Day 4700.75

20 Day 4835.61

26 Day 4870.74

50 Day 5132.86

100 Day 5454.58

200 Day 5473.70

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
SAMPRADA&NANHAMATI SINGH FAMILY TRUSTblockSell21 Feb, 2025₹4,680.006,41,712NSE
SBI MUTUAL FUNDblockBuy21 Feb, 2025₹4,680.006,41,712NSE
SAMPRADA&NANHAMATI SINGH FAMILY TRUSTbulkSell21 Feb, 2025₹4,680.006,41,712NSE
UBS PRINCIPAL CAPITAL ASIA LIMITEDbulkSell25 Nov, 2024₹5,468.999,89,506NSE
SAMPRADA&NANHAMATI SINGH FAMILY TRUSTblockSell22 Aug, 2024₹5,732.158,50,000NSE
TATA MUTUAL FUNDblockBuy22 Aug, 2024₹5,732.1587,000NSE
SOCIETE GENERALEblockBuy22 Aug, 2024₹5,732.1546,000NSE
RELIANCE NIPPON LIFE INSURANCE COMPANY LIMITEDblockBuy22 Aug, 2024₹5,732.1561,000NSE
MORGAN STANLEY ASIA SINGAPORE PTE-ODIblockBuy22 Aug, 2024₹5,732.1598,000NSE
MORGAN STANLEY ASIA SINGAPORE PTEblockBuy22 Aug, 2024₹5,732.1535,000NSE
KOTAK MAHINDRA MUTUAL FUNDblockBuy22 Aug, 2024₹5,732.1561,000NSE
JM FINANCIAL MUTUAL FUNDblockBuy22 Aug, 2024₹5,732.1517,500NSE
SAMPRADA&NANHAMATI SINGH FAMILY TRUSTbulkSell22 Aug, 2024₹5,732.158,50,000NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
29 Mar, 2022Mr. Deepak Kumar SinghDisposal₹3,609.4225,000NSE
08 Mar, 2022Mritunjay Kumar SinghAcquisition₹3,158.041,643NSE
08 Mar, 2022Mritunjay Kumar SinghAcquisition₹3,184.953,357NSE
25 Feb, 2022Dhananjay and Madhurima Singh TrustAcquisition₹3,275.001,050NSE
23 Feb, 2022Dhananjay and Madhurima Singh TrustAcquisition₹3,295.872,000NSE
30 Dec, 2021Mr. Deepak Kumar SinghDisposal₹3,491.172,000NSE
27 Dec, 2021Mr. Deepak Kumar SinghDisposal₹3,437.312,000NSE
23 Dec, 2021Mr. Deepak Kumar SinghDisposal₹3,435.835,000NSE
02 Dec, 2021Jayanti SinhaDisposal₹20,00,000NSE
18 Nov, 2021Deepak Kumar SinghDisposal₹3,572.555,000NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
28 Jan, 2025Rs.37.0000 per share(1850%)Interim Dividend14 Feb, 202514 Feb, 2025
29 May, 2024Rs.5.0000 per share(250%)Final Dividend09 Aug, 202410 Aug, 2024
01 Feb, 2024Rs.35.0000 per share(1750%)Interim Dividend16 Feb, 202417 Feb, 2024

Announcements

DateSourceDetail
31 Mar, 2025NSE IndiaALKEM LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
31 Mar, 2025NSE IndiaAlkem Laboratories Limited has informed the Exchange about Retirement of Mr. Adil Billimoria as Senior Management Personnel of the Company with effect from the closing of business hours of 31st March, 2025
28 Mar, 2025BSE IndiaPursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received orders passed by the statutory authority under the Goods and Services Tax Act, 2017.\r\n\r\nThe relevant disclosure is enclosed herewith.
28 Mar, 2025NSE IndiaAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed
28 Mar, 2025NSE IndiaAlkem Laboratories Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
28 Mar, 2025BSE IndiaIn continuation of our earlier intimation dated 07th February, 2025, we wish to inform you that today i.e. 28th March, 2025, a share purchase agreement has been executed, inter alios, amongst the Company and Adroit.
28 Mar, 2025NSE IndiaAlkem Laboratories Limited has informed the Exchange about General Updates
25 Mar, 2025NSE IndiaMadhurima Singh has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
24 Mar, 2025NSE IndiaAlkem Laboratories Limited has informed the Exchange about Closure of Trading Window
24 Mar, 2025NSE IndiaAlkem Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results & Interim Dividend--29 Jan, 202507 Feb, 2025
Quarterly Results--06 Nov, 202413 Nov, 2024
Quarterly Results--26 Jul, 202409 Aug, 2024
Audited Results & Final Dividend--20 May, 202429 May, 2024
Quarterly Results & Interim Dividend--05 Feb, 202409 Feb, 2024
Quarterly Results--30 Oct, 202307 Nov, 2023
Quarterly Results--02 Aug, 202310 Aug, 2023
Audited Results & Final Dividend--10 May, 202319 May, 2023
Quarterly Results & Interim Dividend--25 Jan, 202310 Feb, 2023
Quarterly Results--03 Nov, 202211 Nov, 2022

Share Holding Pattern

Loading...

Dec 2024Dec 2023Dec 2022Dec 2021Dec 20200255075100
  • Promoter
  • FII
  • DII
  • Public

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group55.66%56.74%57.16%57.13%62.43%
Foreign Institutions +10.14%8.49%4.41%5.4%4.08%
Domestic Institutions +18.01%15.91%16.44%13.94%12.96%
Government0%0%0%0%0%
Public16.19%18.86%21.99%23.53%20.53%
Others0%0%0%0%0%

About Alkem Laboratories

Alkem Laboratories is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 9747.72 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1973

Managing Director

Mr. Sandeep Singh

NSE Symbol

ALKEM

Alkem Laboratories Management

NameDesignation
Mr. Basudeo N SinghExecutive Chairman
Mr. Sandeep SinghManaging Director
Mrs. Madhurima SinghExecutive Director
Mr. Srinivas SinghExecutive Director
Mr. Mritunjay Kumar SinghExecutive Director
Mr. Sarvesh SinghExecutive Director
Mr. Sujjain TalwarIndependent Director
Mr. Arun Kumar PurwarIndependent Director
Ms. Sangeeta SinghIndependent Director
Ms. Sudha RaviIndependent Director
Mr. Narendra Kumar AnejaIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)		₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Alkem Laboratories

What is the share price of Alkem Laboratories?

The share price of Alkem Laboratories on 04 Apr, 2025 is ₹ 4,828.70.

What is 52W high and 52W low share price of Alkem Laboratories?

The highest and lowest 52W share prices of Alkem Laboratories are ₹ 6440.000 and ₹ 4409.900

What is the market cap of Alkem Laboratories?

The market capitalization of Alkem Laboratories as of 04 Apr, 2025 is ₹ 57,734.35 Crores

What is the P/E ratio of Alkem Laboratories?

The current P/E ratio of Alkem Laboratories as of 04 Apr, 2025 is 44.73

What is the PB ratio of Alkem Laboratories?

The PB ratio of Alkem Laboratories as of 04 Apr, 2025 is 5.39

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited